ArticleBMC microbiology2026
Microbiota characteristics in different lung tissue sites of female patients with invasive adenocarcinoma.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThis study aimed to analyze and compare the differences of microbiota in different parts of lung in women with invasive lung adenocarcinoma and further clarify the characteristics of microbiota changes in tumor microenvironment (TME).
methodsThe study patients were all female who underwent lung surgery in our hospital between October 2021 and October 2022. The feasibility of tissue sampling was evaluated by imaging before surgery. Cancerous tissue, paracancerous tissue and normal lung tissue samples were collected from female patients pathologically diagnosed with invasive adenocarcinoma. 16SrRNA sequencing technology was used to detect the diversity, composition distribution and functional characteristics of microbiota in tissue samples.
resultsThere was no significant difference in alpha diversity among bacterial communities at different lung locations in patients with invasive adenocarcinoma (p > 0.05), although a decreasing trend was observed in the Chao1 and ACE indices. Beta diversity analysis revealed that the microbial communities in cancerous and adjacent non-cancerous tissues exhibited similar structures (UniFrac PCoA: p > 0.05), but differed in species abundance (Unweighted UniFrac PCoA: p < 0.05). The microbiota composition is similar across different sites of invasive adenocarcinoma, but differs in species abundance. Compared to normal lung tissue, both tumor and paracancerous tissues show reduced overall species abundance, though Acinetobacter and Comamonas are significantly enriched (p<0.05). Functional predictions further indicated a shift in the tumor microenvironment, with an increase in Gram-negative bacteria, a decrease in Gram-positive bacteria, and a reduction in most microbial metabolic pathways.
conclusionsIn different locations in the lungs of patients with invasive adenocarcinoma, the compositional structure and functional characteristics of the microbiota of cancer and paracancerous tissues were similar and differed significantly from those of normal lung tissues. Species abundance was significantly lower in cancer and paracancerous tissues, with a dominance of Gram-negative bacteria and a reduced abundance of metabolic pathways in the microbiota.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.